qPCR assay | TBEL

top of page

Consortia
Contact Us
If you need information or assistance related to the TBEL Clinical Research Consortium, please contact our team.

We appreciate your interest in our program.
Landing Home
Microsoft Teams (Secure-Site)
Icon representing research studies heading
Consortia Home
News and Events
Publications
Contact Us
Interesting Topics
What are the different types of research?
How does the National Cancer Institute receive funding?
Watch Driving Discovery by the National Institutes of Health (NIH).
Learn more about the Data Coordinating Center (DCC).
Meet the CDMC Principal Investigators
Centers
Icon representing research studies heading
Grantor Organizations
NIH: National Institutes of Health
NCI: National Cancer Institute
Icon representing research studies heading
Awardee Organizations
MD Anderson Cancer Center
Houston Methodist Research Institute
Fred Hutchinson Cancer Center
John Hopkins University
Vanderbilt University Medical Center
Icon representing research studies heading
Cohort Organizations
Cornell University
Cedars-Sinai Medical Center
University of Kansas
University of California
University of Maryland
University of Michigan
University of Washington
University of Wisconsin-Madison
Committees
Executive Committee
Learn More
Steering Committee
Learn More
Icon representing research studies heading
Semi-Annual Meetings
2023: Spring Semi-Annual Meeting
2023: Fall Semi-Annual Meeting
2024: Spring Semi-Annual Meeting
2024: Fall Semi-Annual Meeting
2025: Spring Semi-Annual Meeting
2025: Fall Semi-Annual Meeting
Workgroups
Mechanisms and
Model Systems
Learn More
Digital Pathology and
Pathomics
Learn More
Cell State and
Cell Functions
Learn More
Research Workgroups encourage U54 project collaboration, validate experimental concepts and observations, and ensure overall progress. The program is divided into the following three working groups. These workgroups are facilitated by a designated Chair or Co-Chairs who will oversee the collaboration of each Research Center's progress. The workgroups meet monthly to discuss project status, research initiatives, and innovative concepts.
Data Science
Data Analysis Tools
Learn More
Data Analysis Methods
Learn More
News
Publications

All Categories
Webinar
News
Publications
Data Science
Cancer

Development and validation of a tumor-derived CXCL1 qPCR assay to support patient selection for anti-CXCL1 therapeutics in bladder cancer

Date: June 2026 PMCID: https://pmc.ncbi.nlm.nih.gov/articles/PMC13310799/ Category: N/A Authors: Toru Sakatani, Sunao Tanaka, Kaoru Murakami, Cynthia Jinno, Francisco Aguilar, Catherine Bresee, Owen T M Chan, Daniel J Luthringer, Alberto Contreras-Sanz, Peter Black, Charles J Rosser, Hideki Furuya Abstract: The CXCR2-CXCL1 axis is critical in tumorigenesis, specifically, CXCL1 is a secreted chemokine implicated in tumor progression, angiogenesis, and immune modulation. A

Publications

bgtaylor1

Aug 112 min read